<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04040478</url>
  </required_header>
  <id_info>
    <org_study_id>TCM study</org_study_id>
    <nct_id>NCT04040478</nct_id>
  </id_info>
  <brief_title>Transcutaneous Monitoring of Oxygen and Carbon Dioxide in Surgical Patients</brief_title>
  <official_title>Transcutaneous Monitoring of Oxygen and Carbon Dioxide in Surgical Patients for the Detection of Peripheral Tissue Hypoxia and Hypercapnia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Radiometer Medical ApS</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will investigate if non-invasive continuous transcutaneous blood gas monitoring can&#xD;
      detect tissue perfusion and hypoxemia and the relation to other circulatory parameters such&#xD;
      as pulse, blood pressure, cardiac output and arterial saturation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Macro circulatory parameters such as cardiac output, mean arterial pressure and arterial&#xD;
      oxygen saturation are used to monitor the hemodynamic function and tissue perfusion in&#xD;
      surgical patients. Though none of the methods are directly monitoring changes in the&#xD;
      metabolism of the tissue. Arterial blood gas analysis is used as the golden standard for the&#xD;
      detection of metabolic disturbances before, during and after surgery. Disadvantages of the&#xD;
      method are 1) the fact that the technique is invasive to the patient, 2) that the method&#xD;
      measures the &quot;total gas&quot; (each tissue's contribution to the blood gas in the total&#xD;
      circulating blood) and 3) that the methods only provide a snapshot of the patient's blood gas&#xD;
      status. Transcutaneous monitoring can be used as a continuous monitoring of the underlying&#xD;
      tissue's carbon dioxide and oxygen levels in patients. The method is already used in neonates&#xD;
      as a surrogate for the arterial blood gas analysis. Reduced tissue oxygenation due to&#xD;
      inadequate perfusion, will initiate an anaerobic tissue metabolism resulting in low oxygen&#xD;
      levels and high carbon dioxide levels. The transcutaneous monitoring can therefore&#xD;
      potentially be used to detect tissue hypoxia and become a direct measurement of the&#xD;
      underlying tissue metabolism.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 15, 2019</start_date>
  <completion_date type="Actual">April 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in tcpO2 and tcpCO2 compared to changes in cardiac output, perfusion index and arterial paO2 and paCO2</measure>
    <time_frame>6 hours</time_frame>
    <description>Percentage changes in tcpO2 and tcpCO2 compared to percentage changes in cardiac output, perfusion index and arterial blood gas analysis of paO2 and paCO2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in tcpO2 and tcpCO2 before, during and after the arterial clamping during the surgery.</measure>
    <time_frame>6 hours</time_frame>
    <description>Changes in tcpO2 and tcpCO2 before arterial clamping vs after arterial clamping in the leg undergoing surgery</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Transcutaneous Monitoring</condition>
  <condition>Microcirculation</condition>
  <condition>Peripheral Perfusion</condition>
  <condition>Tissue Metabolism</condition>
  <arm_group>
    <arm_group_label>Abdominal</arm_group_label>
    <description>80 patients undergoing surgery for abdominal cancer. Data review for interim analysis will be conducted after the participation of 40 patients to evaluate the requirement for further enrollment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vascular</arm_group_label>
    <description>20 patients undergoing femoral endarterectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous monitoring</intervention_name>
    <description>Transcutaneous monitoring of oxygen and carbon dioxide by using Radiometer TCM5 flex monitor with 3 electrodes on the patient.&#xD;
Abdominal patients are monitored for 4 hours during surgery and for 2 hours in the Post-Anesthesia Care Unit. Arterial blood gasses are drawn from the arterial line 4 times during surgery and 4 times after surgery.&#xD;
Patients undergoing vascular surgery are monitored for up to 4 hours during surgery.</description>
    <arm_group_label>Abdominal</arm_group_label>
    <arm_group_label>Vascular</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to Rigshospitalet due to surgery for abdominal cancer (Whipple procedure)&#xD;
        and vascular surgery (femoral endarterectomy)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients undergoing surgery for abdominal cancer&#xD;
&#xD;
          -  patients undergoing femoral endarterectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients not able to give a informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eske Aasvang, MD phD DMSci</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>July 29, 2019</study_first_submitted>
  <study_first_submitted_qc>July 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2019</study_first_posted>
  <last_update_submitted>February 22, 2021</last_update_submitted>
  <last_update_submitted_qc>February 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Eske Kvanner Aasvang</investigator_full_name>
    <investigator_title>Head of research, Principal investigator, ass. professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

